期刊
CANADIAN JOURNAL OF CARDIOLOGY
卷 31, 期 11, 页码 1309-1312出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cjca.2015.06.034
关键词
-
资金
- US NIH [R01HL128857]
The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in large part to marked genetic heterogeneity. However, lower costs from next-generation sequencing have enabled gene discovery and the expansion of genetic testing panels. These advances have improved molecular diagnostics and predictive testing in DCM. We provide a rationale and recommendation for clinical genetic testing in all DCM cases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据